These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 32434820)

  • 1. Hydroxychloroquine shortages during the COVID-19 pandemic.
    Mendel A; Bernatsky S; Thorne JC; Lacaille D; Johnson SR; Vinet É
    Ann Rheum Dis; 2021 Mar; 80(3):e31. PubMed ID: 32434820
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and implementation of a virtual Lupus Patient Education Event during the COVID-19 pandemic.
    Maheswaranathan M; English JA; Cunningham MA; Kamen DL
    Lupus Sci Med; 2021 Mar; 8(1):. PubMed ID: 33692151
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
    Mendel A; Bernatsky S; Askanase A; Bae SC; Clarke AE; Costedoat-Chalumeau N; Gladman DD; Gordon C; Hanly J; Jacobsen S; Kalunian K; Mak A; Mosca M; Pons-Estel BA; Ruiz-Irastorza G; Urowitz M; Vinet É
    Ann Rheum Dis; 2021 Feb; 80(2):1-2. PubMed ID: 32586918
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the COVID-19 pandemic on patients with systemic lupus erythematosus: Observations from an Indian inception cohort.
    Rathi M; Singh P; Bi HP; Shivanna A; Kavadichanda C; Tripathy SR; Parthasarathy J; Tota S; Maurya S; Vijayalekshmi V; Bhavani D; Jain A; Gupta R; Danda D; Rajasekhar L; Negi VS; Shobha V; Das B; Aggarwal A
    Lupus; 2021 Jan; 30(1):158-164. PubMed ID: 33019877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the "Infodemic" Threat: A Case Study of the COVID-19 Pandemic.
    Andrew A
    Korean J Fam Med; 2024 Jul; 45(4):183-188. PubMed ID: 38720234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meet the Medicines-A Crowdsourced Approach to Collecting and Communicating Information about Essential Medicines Online.
    Golumbic YN; Scroggie KR; Kenneally CR; Lin J; Blyth MT; Firmer G; Rutledge PJ; Motion A
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practices, knowledge, and attitudes of community pharmacists towards dispensing drugs during the COVID-19 pandemic: A cross sectional study from Jordan.
    Gharaibeh L; Alameri MA; Sibai OA; Alfreahat S; Saeed F; Badran MA; Al-Qaisi A
    Pharm Pract (Granada); 2022; 20(3):2692. PubMed ID: 36733512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Pharmaceutical Compounding in Promoting Medication Adherence.
    Carvalho M; Almeida IF
    Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases.
    Patil A; Chanakya K; Shenoy P; Chandrashekara S; Haridas V; Kumar S; Daware M; Janardana R; Pinto B; Subramanian R; Nagaraj S; Singh YP; Singhai S; Jois R; Jain V; Srinivasa C; Dharmanand BG; Dharmapalaiah C; Sangeetha KN; Rao VK; Shobha V
    BMC Rheumatol; 2022 Jun; 6(1):32. PubMed ID: 35698182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self medication practices and its determinants in health care professionals during the coronavirus disease-2019 pandemic: cross-sectional study.
    Okoye OC; Adejumo OA; Opadeyi AO; Madubuko CR; Ntaji M; Okonkwo KC; Edeki IR; Agboje UO; Alli OE; Ohaju-Obodo JO
    Int J Clin Pharm; 2022 Apr; 44(2):507-516. PubMed ID: 35022953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COVID-19 on Pediatric Immunocompromised Patients.
    Connelly JA; Chong H; Esbenshade AJ; Frame D; Failing C; Secord E; Walkovich K
    Pediatr Clin North Am; 2021 Oct; 68(5):1029-1054. PubMed ID: 34538297
    [No Abstract]   [Full Text] [Related]  

  • 12. Fears about COVID-19 and perceived risk among people with rheumatoid arthritis or ankylosing spondylitis following the initial lockdown in Aotearoa New Zealand.
    Treharne GJ; Johnstone G; Fletcher BD; Lamar RSM; White D; Stebbings S; Harrison A
    Musculoskeletal Care; 2022 Jun; 20(2):290-298. PubMed ID: 34388290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases.
    Hausmann JS; Kennedy K; Simard JF; Liew JW; Sparks JA; Moni TT; Harrison C; Larché MJ; Levine M; Sattui SE; Semalulu T; Foster G; Surangiwala S; Thabane L; Beesley RP; Durrant KL; Mateus EF; Mingolla S; Nudel M; Palmerlee CA; Richards DP; Liew DFL; Hill CL; Bhana S; Costello W; Grainger R; Machado PM; Robinson PC; Sufka P; Wallace ZS; Yazdany J; Sirotich E;
    Lancet Rheumatol; 2021 Oct; 3(10):e707-e714. PubMed ID: 34316727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown.
    Johnstone G; Treharne GJ; Fletcher BD; Lamar RSM; White D; Harrison A; Stebbings S
    Rheumatol Int; 2021 Oct; 41(10):1763-1772. PubMed ID: 34297180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications.
    Haque M; Kumar S; Charan J; Bhatt R; Islam S; Dutta S; Abhayanand JP; Sharma Y; Sefah I; Kurdi A; Wale J; Godman B
    Front Pharmacol; 2020; 11():582154. PubMed ID: 33628172
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19: What Do Rheumatologists Need to Know?
    Fitzgerald GE; Maguire S; Haroon N
    Curr Rheumatol Rep; 2021 Jan; 23(1):5. PubMed ID: 33403528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease.
    Fernandez-Ruiz R; Paredes JL; Niewold TB
    Transl Res; 2021 Jun; 232():13-36. PubMed ID: 33352298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rise and Fall: Hydroxychloroquine and COVID-19 Global Trends: Interest, Political Influence, and Potential Implications.
    Englund TR; Kinlaw AC; Sheikh SZ
    ACR Open Rheumatol; 2020 Dec; 2(12):760-766. PubMed ID: 33263947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 infection in an advanced rheumatoid arthritis patient.
    Bazmjoo A; Bagherzadeh MA; Farahmandpoor F; Raoofi R; Abdoli A
    APMIS; 2020 Dec; 128(12):654-656. PubMed ID: 32945021
    [No Abstract]   [Full Text] [Related]  

  • 20. Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.
    Putman M; Chock YPE; Tam H; Kim AHJ; Sattui SE; Berenbaum F; Danila MI; Korsten P; Sanchez-Alvarez C; Sparks JA; Coates LC; Palmerlee C; Peirce A; Jayatilleke A; Johnson SR; Kilian A; Liew J; Prokop LJ; Murad MH; Grainger R; Wallace ZS; Duarte-García A;
    Arthritis Rheumatol; 2021 Jan; 73(1):36-47. PubMed ID: 32741139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.